Skip to content

A randomized controlled study of the effectiveness of azithromycin in preventing post-respiratory syncytial virus bronchiolitis wheezing

A randomized controlled study of the effectiveness of azithromycin in preventing post-respiratory syncytial virus bronchiolitis wheezing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-07000708
Enrollment
Unknown
Registered
2007-12-18
Start date
2008-02-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-respiratory syncytial virus bronchiolitis wheezing

Interventions

1:Azithromycin for three days
2:placebo

Sponsors

Department of Paediatrics, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
1 Years to 1 Years

Inclusion criteria

Inclusion criteria: 1. previously well infants less than or equal to 12 months of age; 2. first episode of wheezing requiring hospitalization, and with a clinical diagnosis of bronchiolitis. Bronchiolitis is diagnosed based on clinical findings including wheezing or wheezing with crackles preceded by upper respiratory tract infection symptoms, and respiratory distress with retractions; 3. admitted in hospital for 24 hours; 4. laboratory confirmed presence of RSV in nasopharyngeal aspirate, and 5. signed written informed consent.

Exclusion criteria

Exclusion criteria: 1. infants with any cardio-respiratory illness, immunodeficiency or were born prematurely (gestational age <37 weeks); 2. infants who had received corticosteroids within 24 hours before presentation; 3. infants who had received antibiotic treatment less than seven days before hospital admission, and 4. infants requiring mechanical ventilation.

Design outcomes

Primary

MeasureTime frame
the number of wheezing attacks in the following 12 months after the initial illness.;

Secondary

MeasureTime frame
length of hospital stay (LOS) (in hours) defined as the time between study entry;the actual time that the subject is declared fit for discharge.;

Countries

China

Contacts

Public ContactAlbert Martin LI
albertm68mcli@yahoo.com+852 26322859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026